Results 201 to 210 of about 54,210 (294)

Immunoglobulin Light Chain Amyloidosis

Clinical Case Reports, Volume 14, Issue 6, June 2026.
Waxy, purple nodules and plaques distributed across the distal fingers and thenar eminences. ABSTRACT Symmetric, purpuric hand nodules and macroglossia prompted skin biopsy revealing immunoglobulin light chain amyloidosis, leading to the diagnosis of multiple myeloma.
Justin Lyon, Ashley Khouri, Katheryn A. Bell, Jamie Zussman   +3 more
wiley   +1 more source

The molecular landscape of AL amyloidosis. [PDF]

Br J Haematol
Zvida-Bloch T, Muchtar E, Dispenzieri A, Shpilberg O, Hershkovitz-Rokah O.   +4 more
europepmc   +1 more source

An Unusual Cause of Diffuse Bone Pain in a Long‐Term Dialysis Patient: A Case Report of β2‐Microglobulin Amyloid Arthropathy

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Dialysis‐related amyloidosis (DRA) results from β2‐microglobulin accumulation in patients on long‐term hemodialysis, typically manifesting after 5–10 years. While well‐documented in developed countries, reports from sub‐Saharan Africa remain scarce.
Yannick Laurent Tchenadoyo Bayala, Mohamed Hanas Mama Sika, Marina Saley André Hamidou, Issa Ouedraogo, Rachidatou Kafando, Bakoubassé Aïssata Son, Wendyam Nadège Yameogo, Wendlassida Joëlle Stéphanie Zabsonré/Tiendrébéogo, Dieu‐Donné Ouedraogo   +8 more
wiley   +1 more source

Progressive Macroglossia and Dysphagia as the Initial Manifestation of Systemic Amyloid Light-Chain (AL) Amyloidosis Associated With Multiple Myeloma: A Case Report and Literature Review. [PDF]

Cureus
Biswas N, Almahmood M, Mandal S, Potdar R, Fu JJ.   +4 more
europepmc   +1 more source

Myocardial deformation imaging to monitor treatment response in AL amyloidosis: is it worth the strain? [PDF]

Eur Heart J Open
Castiglione V, Gentile F, Vergaro G.
europepmc   +1 more source

Delivering Proteins and Enzymes to Solid Tumors Through the Development of Stimuli‐Responsive Nanocarriers

ChemNanoMat, Volume 12, Issue 6, June 2026.
Stimuli‐responsive strategies to achieve controlled release of protein‐based therapeutic agents into solid tumors. Proteins, enzymes, and peptides have long been recognized as valuable therapeutic agents, particularly in oncology. However, their complex chemical structures render them more sensitive than smaller chemotherapeutic drugs.
Guillermo Plaza‐Palomo, Diana Benita‐Donadios, Sandra Jiménez‐Falcao, Alejandro Baeza   +3 more
wiley   +1 more source

Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus‐Associated Disorders

Cancer Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Kaposi sarcoma herpes virus (KSHV) is associated with multiple clinical manifestations, including primary effusion lymphoma, an aggressive CD38+ B cell lymphoma with a plasmablastic phenotype. Case This case describes an antiretroviral therapy‐adherent person with HIV who presented with concurrent KSHV‐related disorders of Kaposi ...
Kandice Roberts, Paula Valiño Ramos, Saurabh Jindal, Vikas Prasad, Yi Shan Lee, Mariam Khanfar, Obi L. Griffith, Malachi Griffith, Jeanne Jiang, Ethel Cesarman, Daniel Rauch, Paul Simonson, Thomas Odeny, Lee Ratner   +13 more
wiley   +1 more source

Hematologic response and kidney outcomes of monoclonal gammopathy of renal significance excluding AL amyloidosis: a report of six cases. [PDF]

BMC Nephrol
Nobayashi H, Haruhara K, Nakamura T, Shiina Y, Katsuma A, Okabe M, Suzuki K, Tsuboi N, Yano S, Yokoo T.   +9 more
europepmc   +1 more source

Causal Effects of Hydrophilic Bile Acids on Carfilzomib‐Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study

Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1494-1502, June 2026.
Carfilzomib is highly effective in the treatment of multiple myeloma, but it has been associated with cardiovascular adverse events that impact patient outcomes. Our prior global metabolomic analyses indicated an association between hydrophilic bile acids and carfilzomib‐cardiotoxicity risk, although a causal relationship remained to be determined ...
Samia Shabnaz, Eric Farber‐Eger, Marwa Tantawy, Neyousha Shahisavandi, Timothy J. Garrett, Samuel M. Rubinstein, Michael G. Fradley, Mohammed E. Alomar, Danny DeAvila, Kenneth H Shain, R. Frank Cornell, Daniel Lenihan, Qing Lu, Quinn S Wells, Rachid C. Baz, Yan Gong   +15 more
wiley   +1 more source

Comparative evaluation of free light chain assays in AL amyloidosis: Performance of Sebia versus Freelite and N-Latex. [PDF]

Pract Lab Med
Zhao F, Pretorius C, Mollee P.
europepmc   +1 more source